Old Web
English
Sign In
Acemap
>
Paper
>
Effectiveness of very low-dose intravitreous bevacizumab for retinopathy of prematurity
Effectiveness of very low-dose intravitreous bevacizumab for retinopathy of prematurity
2021
David K. Wallace
Raymond T. Kraker
Sharon F. Freedman
Eric R. Crouch
Amit R. Bhatt
Mary Elizabeth Hartnett
Michael B. Yang
David L. Rogers
Amy K. Hutchinson
Deborah K. VanderVeen
Kathryn M. Haider
R. Michael Siatkowski
Trevano W. Dean
Michael X. Repka
Lois E. H. Smith
William V. Good
Lingkun Kong
Susan A. Cotter
Jonathan M. Holmes
Keywords:
Ophthalmology
low dose
Medicine
Retinopathy of prematurity
Bevacizumab
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]